PUBLISHER: Polaris Market Research | PRODUCT CODE: 1388148
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1388148
The global hemianopsia market size is expected to reach USD 676.29 million by 2032, according to a new study by Polaris market research. The report "Hemianopsia Market Share, Size, Trends, Industry Analysis Report, By Type (Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia); By Treatment; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing awareness among healthcare professionals, patients, and the general public about visual impairments, including hemianopsia, leading demand for early diagnosis and appropriate treatment, along with the investment in research and clinical trials helping validate the efficacy of new treatments and diagnosis, are prominent factors propelling the overall market growth.
The rapid development of diagnostic tools, such as advanced imaging techniques and visual field-testing methods, that results in improving accuracy and efficiency in diagnosing hemianopsia and innovations in neuro-rehabilitation therapies, which include virtual reality, computer-based training, and neuro-stimulation techniques, has also been among the factors creating lucrative growth opportunities for the market. For instance, in April 2023, Sensoria Health announced the launch of its new wearable system named NeurOpTrek, powered by Sensoria, which is designed to improve vision and help to reduce the risk of falls, a serious health concern mainly for older adults.
The surging technology integration across various types of devices and systems, including wearable devices, virtual reality systems, mobile applications, and computer-based training programs, mainly to assist individuals with hemianopsia in various aspects of their daily lives and the ability of these technologies to compensate for visual field deficits, enhance functional vision, and support independence and quality of life, are among the most emerging trends in the global market.
Additionally, there has been a growing emphasis on neuroplasticity and rehabilitation approaches in the treatment of hemianopsia in recent years, and a surging number of researchers and clinicians are exploring techniques that promote cortical reorganization and functional recovery of the visual field through targeted training coupled with the proliferation for awareness campaigns, educational materials, and conferences, contributing to improved recognition and management of hemianopsia all over the world.
Homonymous hemianopsia segment accounted for largest global market share in 2022, owing to increasing prevalence of diseases as common visual impairment due to different causes including tumors and stroke
Vision restoration therapy segment held the maximum market revenue share in 2022, which is mainly driven by rising number of regulatory agencies recognizing the importance of these therapies
Specialty clinics segment is projected to emerge as fastest growing region with a significant CAGR over the study period, due to rising incorporation of advanced novel therapies
North America region led the industry market with substantial share in 2022, on account of robust presence of developed healthcare infrastructure and number of surgeries being performed across the region
The global key market players include: F. Hoffman-La Roche, Novartis AG, Aerie Pharmaceuticals, AkzoNobel N.V., AbbVie Inc., EyeTech Digital Systems, and NeuroVision Imaging LLC
Polaris market research has segmented the Hemianopsia market report based on type, treatment, end user, and region: